Ensysce Biosciences (ENSC) Short Interest Ratio & Short Volume → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free ENSC Stock Alerts $0.56 -0.01 (-1.75%) (As of 05/3/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Ensysce Biosciences Short Interest DataCurrent Short Volume4,100 sharesPrevious Short Volume17,500 sharesChange Vs. Previous Month-76.57%Dollar Volume Sold Short$2,785.95Short Interest Ratio / Days to Cover0.0Last Record DateApril 15, 2024Outstanding Shares7,330,000 sharesFloat Size2,850,000 sharesShort Percent of Float0.14%Today's Trading Volume155,192 sharesAverage Trading Volume92,738 sharesToday's Volume Vs. Average167% Short Selling Ensysce Biosciences ? Sign up to receive the latest short interest report for Ensysce Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatENSC Short Interest Over TimeENSC Days to Cover Over TimeENSC Percentage of Float Shorted Over Time Ad Weiss RatingsFW: 234x GainThis coin is an essential building block for an ongoing financial revolution of massive dimensions. As a big part of this revolution, the big banks of the world must connect to the blockchain.Click here. Ensysce Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20244,100 shares $2,785.95 -76.6%0.1%0 $0.68 3/31/202417,500 shares $13,828.50 -69.0%0.6%0 $0.79 3/15/202456,500 shares $44,838.40 -34.4%1.9%0 $0.79 2/29/202486,100 shares $80,279.64 +40.9%3.0%0.1 $0.93 2/15/202461,100 shares $54,379.00 -91.0%2.1%0 $0.89 1/31/2024678,500 shares $1.10 million +175.5%23.3%0.5 $1.62 Get the Latest News and Ratings for ENSC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ensysce Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024246,300 shares $337,431.00 +9.1%8.8%0.2 $1.37 12/31/2023225,700 shares $239,242.00 +35.2%8.0%1 $1.06 12/15/2023167,000 shares $185,370.00 +25.3%5.9%0.8 $1.11 11/30/2023133,300 shares $151,962.00 +96.6%4.8%0.9 $1.14 11/15/202367,800 shares $59,806.38 +11.3%2.4%0.9 $0.88 10/31/202360,900 shares $56,094.99 +161.4%2.2%0.8 $0.92 10/15/202323,300 shares $33,552.00 +9.9%0.9%0.3 $1.44 9/30/202321,200 shares $29,256.00 -20.0%0.8%0.4 $1.38 9/15/202326,500 shares $46,375.00 -4.0%1.1%0.1 $1.75 8/31/202327,600 shares $51,060.00 -2.1%1.1%0.1 $1.85 8/15/202328,200 shares $54,990.00 -36.8%1.0%0.1 $1.95 7/31/202344,600 shares $89,646.00 +81.3%1.9%0.1 $2.01 7/15/202324,600 shares $48,216.00 +24.9%1.4%0 $1.96 6/30/202319,700 shares $36,051.00 -2.5%2.4%0 $1.83 6/15/202320,200 shares $47,470.00 +6.3%2.5%0 $2.35 5/31/202319,000 shares $45,030.00 -83.3%2.3%0 $2.37 5/15/2023113,600 shares $349,888.00 +43.8%11.0%0.2 $3.08 4/30/202379,000 shares $296,250.00 +62.2%6.3%0.1 $3.75 4/15/202348,700 shares $194,366.57 +5.9%3.9%0.2 $3.99 3/31/202346,000 shares $2.68 million -92.1%6.9%0.2 $58.32 3/15/2023580,700 shares $351,904.20 +194.3%17.3%0.3 $0.61 2/28/2023197,300 shares $96,479.70 -28.3%5.7%0.1 $0.49 2/15/2023275,200 shares $167,872.00 -47.6%7.2%0.1 $0.61 1/31/2023525,000 shares $367,500.00 +631.2%9.9%0.2 $0.70 1/15/202371,800 shares $55,321.90 -9.9%1.6%0 $0.77 12/30/202279,700 shares $59,775.00 -44.4%1.7%0.1 $0.75 12/15/2022143,400 shares $131,340.06 -54.6%7.1%0.1 $0.92 11/30/2022315,700 shares $915,530.00 +128.9%17.3%0.3 $2.90 11/15/2022137,900 shares $297,864.00 -8.1%7.5%0.2 $2.16 10/31/2022150,000 shares $484,500.00 -78.5%10.1%0.8 $3.23 10/15/2022698,700 shares $144,630.90 -39.8%3.2%0.5 $0.21 9/30/20221,160,000 shares $249,400.00 -27.5%5.3%1.1 $0.22 9/15/20221,600,000 shares $551,840.00 +134.6%7.4%1 $0.34 8/31/2022681,900 shares $288,034.56 -5.0%3.3%0.5 $0.42Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. ENSC Short Interest - Frequently Asked Questions What is Ensysce Biosciences' current short interest? Short interest is the volume of Ensysce Biosciences shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 4,100 shares of ENSC short. 0.14% of Ensysce Biosciences' shares are currently sold short. Learn More on Ensysce Biosciences' current short interest. What is a good short interest percentage for Ensysce Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.14% of Ensysce Biosciences' floating shares are currently sold short. Is Ensysce Biosciences' short interest increasing or decreasing? Ensysce Biosciences saw a decline in short interest in April. As of April 15th, there was short interest totaling 4,100 shares, a decline of 76.6% from the previous total of 17,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Ensysce Biosciences' float size? Ensysce Biosciences currently has issued a total of 7,330,000 shares. Some of Ensysce Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Ensysce Biosciences currently has a public float of 2,850,000 shares. How does Ensysce Biosciences' short interest compare to its competitors? 0.14% of Ensysce Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Ensysce Biosciences: Genprex, Inc. (2.69%), Longeveron Inc. (9.34%), Tharimmune, Inc. (0.90%), Bright Minds Biosciences Inc. (2.76%), Artelo Biosciences, Inc. (0.19%), Exicure, Inc. (2.01%), Petros Pharmaceuticals, Inc. (1.69%), GT Biopharma, Inc. (0.27%), Lipella Pharmaceuticals Inc. (1.49%), NexImmune, Inc. (0.89%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Ensysce Biosciences stock? Short selling ENSC is an investing strategy that aims to generate trading profit from Ensysce Biosciences as its price is falling. ENSC shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ensysce Biosciences? A short squeeze for Ensysce Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ENSC, which in turn drives the price of the stock up even further. How often is Ensysce Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENSC, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Genprex Short Interest Longeveron Short Interest Tharimmune Short Interest Bright Minds Biosciences Short Interest Artelo Biosciences Short Interest Exicure Short Interest Petros Pharmaceuticals Short Interest GT Biopharma Short Interest Lipella Pharmaceuticals Short Interest NexImmune Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ENSC) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldUrgent Nvidia WarningAltimetryThe asset beating inflation by 4xColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace